Edition:
United States

PAREXEL International Corp (PRXL.OQ)

PRXL.OQ on NASDAQ Stock Exchange Global Select Market

87.99USD
22 Sep 2017
Change (% chg)

-- (--)
Prev Close
$87.99
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
287,709
52-wk High
$88.07
52-wk Low
$51.18

Chart for

About

PAREXEL International Corporation (PAREXEL) is a biopharmaceutical outsourcing services company. The Company provides a range of expertise in clinical research, clinical logistics, medical communications, consulting, commercialization, and technology products and services to pharmaceutical, biotechnology and medical device... (more)

Overall

Beta: 0.77
Market Cap(Mil.): $4,497.64
Shares Outstanding(Mil.): 51.12
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 81.40 16.08
EPS (TTM): -- -- --
ROI: -- 3.18 14.60
ROE: -- 4.93 14.03

BRIEF-Parexel's sharehodlers approve proposed acquisition by Pamplona Capital Management

* Parexel International receives shareholder approval for proposed acquisition by Pamplona Capital Management

Sep 18 2017

EU mergers and takeovers (Aug 30)

BRUSSELS, Aug 30 The following are mergers under review by the European Commission and a brief guide to the EU merger process:

Aug 30 2017

EU mergers and takeovers (Aug 29)

BRUSSELS, Aug 29 The following are mergers under review by the European Commission and a brief guide to the EU merger process:

Aug 29 2017

EU mergers and takeovers (Aug 25)

BRUSSELS, Aug 25 The following are mergers under review by the European Commission and a brief guide to the EU merger process:

Aug 25 2017

BRIEF-Parexel International forms alliance with Osaka International Cancer Institute​

* Parexel International Corp - ‍Formed an alliance to advance clinical development in Japan with Osaka International Cancer Institute​ Source text for Eikon: Further company coverage:

Aug 21 2017

BRIEF-Parexel International Corp announces $720 million senior notes offering by West Street Merger Sub

* PAREXEL International Corporation announces $720 million senior notes offering by West Street Merger Sub Inc

Aug 07 2017

Quintiles IMS explores sale of contract sales business: sources

Clinical researcher and pharmaceutical market data specialist Quintiles IMS Holdings Inc is exploring a sale of its contract sales business that could value it at as much as $1 billion, according to people familiar with the matter.

Jun 21 2017

Quintiles IMS explores sale of contract sales business -sources

June 21 Clinical researcher and pharmaceutical market data specialist Quintiles IMS Holdings Inc is exploring a sale of its contract sales business that could value it at as much as $1 billion, according to people familiar with the matter.

Jun 21 2017

Pamplona Capital to take Parexel private for $4.5 billion

U.S. pharmaceutical research services provider Parexel International Corp said on Tuesday it would be taken private by Pamplona Capital Management LLP in a $4.5 billion deal.

Jun 20 2017

UPDATE 3-Pamplona Capital to take Parexel private for $4.5 bln

June 20 U.S. pharmaceutical research services provider Parexel International Corp said on Tuesday it would be taken private by Pamplona Capital Management LLP in a $4.5 billion deal.

Jun 20 2017

Earnings vs. Estimates